Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILENT TECHNOLOGIES, INC.

(A)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Agilent Technologies : Wells Fargo Adjusts Agilent Technologies' Price Target to $150 From $140, Maintains Overweight Rating

05/26/2021 | 08:58am EDT


ę MT Newswires 2021
All news about AGILENT TECHNOLOGIES, INC.
08/04AGILENT TECHNOLOGIES : Earns 2021 Great Place to Work Certification in the U.S.
BU
08/03Agilent Technologies, Inc. Announces Target Enrichment Manufacturing Facility..
CI
08/03AGILENT TECHNOLOGIES : Announces Target Enrichment Manufacturing Facility in Chi..
PU
07/28AGILENT TECHNOLOGIES INC. : - Clinical Utility of ALK Fusion Detection by Liquid..
AQ
07/28AGILENT TECHNOLOGIES : Early Career Professor Award Presented to Jason H. Yang
BU
07/27AGILENT TECHNOLOGIES : Clinical Utility of ALK Fusion Detection by Liquid Biopsy
BU
07/22AGILENT TECHNOLOGIES : Celebrates More than 20 Years of Sustainable Progress
BU
07/21AGILENT TECHNOLOGIES : to Webcast Third-Quarter Fiscal Year 2021 Financial Resul..
BU
07/20Agilent Technologies PharmDx Assay Receives Expanded Use in EU
MT
07/20Agilent Technologies Inc. Announces That the PD-L1 IHC 22C3 PharmDx Assay Is ..
CI
More news
Financials (USD)
Sales 2021 6 221 M - -
Net income 2021 1 039 M - -
Net Debt 2021 1 487 M - -
P/E ratio 2021 45,5x
Yield 2021 0,51%
Capitalization 46 812 M 46 812 M -
EV / Sales 2021 7,76x
EV / Sales 2022 7,32x
Nbr of Employees 16 500
Free-Float 99,3%
Chart AGILENT TECHNOLOGIES, INC.
Duration : Period :
Agilent Technologies, Inc. Technical Analysis Chart | A | US00846U1016 | MarketScreener
Technical analysis trends AGILENT TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Last Close Price 154,27 $
Average target price 146,31 $
Spread / Average Target -5,16%
EPS Revisions
Managers and Directors
Michael R. McMullen President, Chief Executive Officer & Director
Robert W. McMahon Chief Financial Officer & Senior Vice President
Koh Boon Hwee Non-Executive Chairman
Darlene J. S. Solomon Chief Technology Officer & Senior Vice President
Katharine Knobil Chief Medical Officer
Sector and Competitors